Kizoo invests in groundbreaking technologies targeting the root causes of aging to extend healthy lifespans. Their portfolio includes companies developing rejuvenation therapies for blood vessels, arterial plaque removal, calcification reversal, crosslink-breaking drugs, stem cell rejuvenation, and therapeutic mitochondria transfer. Historically, they have also backed Germany’s Internet & SaaS unicorns.
Bevorzugte Reifephase für die erste Finanzierung.
Never-done-before technologies in rejuvenation biotech and longevity, as well as seed and mentorship investments in Internet & SaaS (historically)
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...